<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The transcription factor <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> gene 1 (WT1) is important as a prognostic marker as well as in the detection and monitoring of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> in <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Evidence has accumulated over the past decade to show that WT1 is a key molecule for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> proliferation in a large number of human <z:hpo ids='HP_0002664'>neoplasms</z:hpo> most prominent in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath>, making it a suitable target for therapeutic strategies </plain></SENT>
<SENT sid="2" pm="."><plain>Based on animal results, showing safety and efficacy of immunization with WT1 <z:chebi fb="7" ids="16670">peptides</z:chebi> and protein, early clinical trials in <z:mpath ids='MPATH_336'>leukaemia</z:mpath> have recently been initiated </plain></SENT>
<SENT sid="3" pm="."><plain>The First International Conference on WT1 in Human <z:hpo ids='HP_0002664'>Neoplasia</z:hpo> was held in Berlin, March 11--12, 2004 </plain></SENT>
<SENT sid="4" pm="."><plain>This report reviews the current knowledge on the role of WT1 in <z:e sem="disease" ids="C1519689" disease_type="Neoplastic Process" abbrv="">tumour promotion</z:e> and as a diagnostic and therapeutic target, and summarizes the data presented and discussed in this meeting </plain></SENT>
</text></document>